Self-medication: Risks and Benefits
نویسندگان
چکیده
منابع مشابه
Nanocosmetics: benefits and risks
Various nanomaterials/nanoparticles (NPs) have been used for the development of cosmetic products - a field so-called nanocosmetic formulations. These advanced materials offer some benefits, while their utilization in the cosmetic formulations may be associated with some risks. The main aim of this editorial is to highlight the benefits and risks of the nanomaterials used in the cosmetic products.
متن کاملClozapine: benefits and risks.
The National Institute of Mental Health and Dr. David Shore are to be thanked and congratulated for the very complete and informative issue of the Schizophrenia Bulletin entitled "Special Report: Schizophrenia 1993." Somehow the dangers of clozapine have been grossly exaggerated. Let us look at the facts. There are now over 60,000 patients being treated with clozapine in the United States. Ther...
متن کاملXenotransplantation: benefits and risks.
545 able organic carbon level, degree of pipe corrosion, and treatment/distribution system characteristics. Chloramine is considerably more effective than chlorine for controlling Legionella in biofilms, presumably because chloramine is more stable and thus less reactive than chlorine, allowing it to penetrate the biofilm more deeply. An important factor in distribution system contamination and...
متن کاملCharacterization of Apps and Other e-Tools for Medication Use: Insights Into Possible Benefits and Risks
BACKGROUND In the past years, an enormous increase in the number of available health-related applications (apps) has occurred, from approximately 5800 in 2011 to over 23,000 in 2013, in the iTunes store. However, little is still known regarding the use, possible effectiveness, and risks of these applications. In this study, we focused on apps and other e-tools related to medicine use. A large s...
متن کاملInfluence of medication risks and benefits on treatment preferences in older patients with multimorbidity
Multimorbidity is associated with use of multiple medicines, increased risk of adverse events and treatment conflicts. This study aimed to examine how older patients with multimorbidity and clinicians balance the benefits and harms associated with a medication and in the presence of competing health outcomes. Interviews were conducted with 15 participants aged ≥65 years with 2 or more chronic c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Pharmacology
سال: 2011
ISSN: 1811-7775
DOI: 10.3923/ijp.2012.58.59